mots 40 mg
MOTS-c 40 mg Mitochondrial Peptide Research USA
MOTS-c 40 mg Mitochondrial-Derived Research Peptide USA Overview of MOTS-c 40 mg MOTS-c 40 mg is a synthetic mitochondrial-derived peptide supplied exclusively for laboratory and scientific research applications in the United States. This higher-quantity format is suitable for advanced experimental designs where MOTS-c is studied for its molecular properties, stability, and interaction within cellular research models. HK Peptides Worldwide provides MOTS-c strictly for research use only. This product is not intended for human or veterinary use. Research Characteristics of MOTS-c Mitochondrial-Derived Peptide Structure MOTS-c is classified as a mitochondrial-encoded peptide and is widely examined in research environments focused on cellular metabolism, mitochondrial signaling, and molecular interaction studies. Laboratory-Controlled Synthesis and Purity The 40 mg concentration supports extended or multi-phase laboratory research protocols while maintaining consistent peptide integrity and batch reliability. Secure Packaging for U.S. Research Facilities Each vial is sealed and packaged according to laboratory handling standards to preserve peptide stability during storage and distribution within the United States. Research Applications MOTS-c 40 mg is commonly utilized in mitochondrial signaling research , cellular metabolism studies , and biochemical pathway analysis conducted under controlled in-vitro laboratory conditions. This product is supplied exclusively for professional scientific research use. Advantages and Limitations Advantages High-quantity format for extended mitochondrial research Suitable for advanced metabolic and cellular studies Consistent synthesis for reproducible laboratory outcomes Secure, research-grade packaging for USA laboratories Limitations Not approved for human, animal, or clinical use No therapeutic, medical, or diagnostic applications Restricted strictly to laboratory and scientific research Frequently Asked Questions (FAQ) 1. What type of research commonly uses MOTS-c 40 mg? It is commonly used in mitochondrial signaling studies, cellular metabolism research, and controlled biochemical experiments. 2. Is MOTS-c 40 mg approved for medical or personal use? No. MOTS-c 40 mg is supplied strictly for research purposes only. 3. Why choose the 40 mg concentration? The 40 mg format supports laboratories conducting extended research protocols or multiple experimental trials.
Expanded Research Background & Molecular Mechanisms
Structural Identity & Pharmacological Classification
MOTS-C (Mitochondrial-Derived Peptide) is supplied as a 40 mg research-grade lyophilized powder for controlled laboratory investigation. CAS: 1628322-46-2. The molecular architecture — H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH — confers specific structural features that determine receptor binding kinetics, metabolic stability, and biological activity profiles relevant to preclinical research applications. Each batch is synthesized under strictly controlled solid-phase peptide synthesis (SPPS) conditions using Fmoc chemistry, purified via preparative reverse-phase HPLC, and verified through comprehensive analytical characterization including high-resolution mass spectrometry and amino acid analysis.
Primary Mechanism of Action
The biological activity of MOTS-C is mediated through high-affinity interaction with its cognate receptor(s). Upon receptor engagement, conformational changes in the receptor-ligand complex trigger intracellular signaling cascades involving G-protein coupling, second messenger generation (cAMP, IP3, Ca²⁺), and downstream kinase activation. These signaling events culminate in transcriptional reprogramming of target genes through activation of transcription factors including CREB, NF-κB, and AP-1, depending on the specific receptor system and cell type under investigation. The concentration-response relationship typically follows classical sigmoidal kinetics with EC₅₀ values in the nanomolar to micromolar range, making MOTS-C suitable for dose-response experimental designs across multiple biological replicate conditions.
Downstream Signaling & Cellular Responses
Research investigations have elucidated several key downstream pathways activated by MOTS-C:
-
MAPK/ERK Cascade: Receptor activation → Ras → Raf → MEK → ERK1/2 phosphorylation → nuclear translocation → transcription of immediate-early genes (c-Fos, c-Jun, Egr-1) → cellular proliferation and differentiation responses. This pathway is particularly relevant in tissue remodeling, wound healing, and regenerative biology research contexts.
-
PI3K/Akt/mTOR Axis: Parallel signaling through PI3K → PIP₃ → PDK1 → Akt phosphorylation (Thr308, Ser473) → mTORC1 activation → enhanced protein translation via 4E-BP1 and S6K1 phosphorylation. This pathway supports anabolic signaling, cell survival, and metabolic reprogramming studies.
-
JAK/STAT Pathway: In cytokine-responsive systems, MOTS-C-mediated receptor dimerization recruits JAK kinases → STAT protein phosphorylation → STAT dimerization → nuclear translocation → target gene transcription. This pathway is central to immunomodulation and hematopoietic research.
-
Calcium Mobilization: Gαq-coupled signaling → PLCβ activation → IP₃-mediated Ca²⁺ release from ER stores → calmodulin-dependent kinase (CaMK) activation → diverse cellular responses including secretion, contraction, and gene expression.
Pharmacokinetic Considerations for Research Design
For laboratory research applications, several pharmacokinetic parameters inform experimental design:
- Reconstitution: Lyophilized MOTS-C should be reconstituted in sterile, preservative-free aqueous buffer (PBS pH 7.4 or sterile water) to the desired stock concentration. Gentle swirling — not vortexing — is recommended to prevent peptide aggregation and ensure complete dissolution.
- Stability: Reconstituted solutions maintain full biological activity for up to 30 days when stored at 2–8°C, protected from light. For extended storage, aliquot into single-use volumes and store at -20°C or -80°C. Avoid repeated freeze-thaw cycles, which can cause 3–8% activity loss per cycle due to peptide aggregation and potential oxidation of sensitive residues.
- Working Concentrations: Typical in vitro working concentrations range from 1 nM to 100 μM, depending on the assay system and experimental endpoint. Preliminary dose-ranging experiments (logarithmic dilution series: 0.1, 1, 10, 100, 1000 nM and 1, 10, 100 μM) are recommended to establish the optimal concentration range for each specific research application.
Comparative Pharmacology & Research Context
MOTS-C occupies a distinct position within the broader peptide research landscape. Compared to structurally related compounds, MOTS-C exhibits unique receptor selectivity profiles, signaling bias characteristics (G-protein vs. β-arrestin coupling), and pharmacokinetic properties that make it a valuable tool for dissecting specific biological pathways. Researchers should consider the following when designing comparative studies:
- Receptor Selectivity: Verify receptor specificity through competitive binding assays using pharmacologically relevant concentrations of selective antagonists.
- Signaling Bias: Quantify both G-protein-mediated (cAMP, IP₁ accumulation) and β-arrestin-mediated (receptor internalization, ERK phosphorylation) signaling to fully characterize functional selectivity.
- Batch Consistency: For multi-phase research programs spanning extended time periods, procure peptide from the same manufacturing batch to eliminate batch-to-batch variability as a confounding factor.
Quality Control Verification Protocol
Before initiating experimental procedures, researchers should verify:
- Peptide identity by mass spectrometry (observed MW within ±1.0 Da of theoretical)
- Purity ≥98% by analytical HPLC at 214 nm
- Peptide content ≥80% by quantitative amino acid analysis
- Endotoxin levels ≤1.0 EU/mg (critical for cell-based assays)
- Visual inspection: white to off-white lyophilized powder with no discoloration or clumping
These verification steps ensure experimental reproducibility and data integrity across research programs.
Related Research & Resources
| Resource | Description |
|---|---|
| Glp 1 Metabolic Peptides Hub | Complete research overview & methodology hub |
| Mots C 10 Mg Mitochondrial Peptide Suppl | Related research peptide product |
| Mots C 20 Mg Mitochondrial Peptide Resea | Related research peptide product |
| Glp 1 Peptides Metabolic Research | Latest research insights & methodology |